Loading clinical trials...
Loading clinical trials...
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Conditions
Interventions
GSK2894512 1% Cream
GSK2894512 0.5% Cream
+1 more
Locations
46
United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
North Logan, Connecticut, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Chicago, Illinois, United States
GSK Investigational Site
Plainfield, Indiana, United States
GSK Investigational Site
Overland Park, Kansas, United States
Start Date
November 23, 2015
Primary Completion Date
October 1, 2016
Completion Date
October 5, 2016
Last Updated
November 13, 2017
NCT07474792
NCT06857942
NCT06979453
NCT07471048
NCT07449234
NCT07116967
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions